Kypha raises $4m to expand capabilities of Irish subsidary Biosensia
US company acquired NovaUCD-based biotech firm for an undisclosed sum in July
Dublin-based Biosensia acquired by US company Kypha
NovaUCD-based company has point-of-care in-vitro diagnosis system known as RapiPlex
Biosensia screening test set to speed up diagnosis of head trauma
Diagnostic platform RapiPlex due to arrive on market in about two years’ time
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices